T Lauritzen Selected Research

T Lauritzen Research Topics

Disease

21	Type 2 Diabetes Mellitus (MODY) 12/2016 - 09/2000
7	Glucose Intolerance 08/2014 - 11/2003
4	Insulin Resistance 02/2013 - 01/2008
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2011 - 03/2005
3	Birth Weight (Birth Weights) 01/2004 - 12/2000
2	Chronic Disease (Chronic Diseases) 12/2014 - 07/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2014 - 01/2004
2	Obesity 11/2011 - 05/2010
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2016
1	Albuminuria 12/2016
1	Peripheral Nervous System Diseases (PNS Diseases) 06/2015
1	Diabetic Neuropathies (Diabetic Neuropathy) 06/2015
1	Inflammation (Inflammations) 07/2013
1	Body Weight (Weight, Body) 07/2013
1	Overweight 07/2013
1	Stroke (Strokes) 02/2011
1	Hypertension (High Blood Pressure) 02/2008
1	Weight Loss (Weight Reduction) 02/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2005
1	Heart Diseases (Heart Disease) 03/2004
1	Diabetes Mellitus 01/2004
1	Neoplasms (Cancer) 01/2004
1	Vascular Diseases (Vascular Disease) 09/2001
1	Tinnitus 05/2001
1	Coronary Disease (Coronary Heart Disease) 12/2000
1	Diabetes Complications 09/2000

Drug/Important Bio-Agent (IBA)

16	Glucose (Dextrose)FDA LinkGeneric 06/2015 - 09/2000
7	Insulin (Novolin)FDA Link 02/2013 - 11/2006
5	Insulin Aspart (NovoLog)FDA Link 02/2011 - 12/2005
4	LipidsIBA 12/2014 - 12/2000
3	Hypoglycemic Agents (Hypoglycemics)IBA 03/2011 - 09/2000
3	CholesterolIBA 03/2011 - 12/2000
3	Blood Glucose (Blood Sugar)IBA 04/2008 - 09/2005
3	insulin aspart protamine drug combination 30:70 insulin aspartIBA 11/2006 - 03/2005
2	AlbuminsIBA 12/2016 - 09/2001
2	CreatinineIBA 12/2016 - 09/2001
2	Pyruvaldehyde (Methylglyoxal)IBA 12/2016 - 06/2015
2	Biomarkers (Surrogate Marker)IBA 07/2013 - 02/2012
2	Triglycerides (Triacylglycerol)IBA 02/2008 - 01/2008
1	Dopamine Receptors (Dopamine Receptor)IBA 08/2014
1	Urokinase Plasminogen Activator ReceptorsIBA 07/2013
1	HDL CholesterolIBA 02/2013
1	Glucagon (Glukagon)FDA Link 11/2011
1	Hormones (Hormone)IBA 11/2011
1	OxyntomodulinIBA 11/2011
1	Glucagon-Like Peptides (Enteroglucagon)IBA 11/2011
1	Hepatocyte Nuclear FactorsIBA 01/2011
1	Transcription Factors (Transcription Factor)IBA 01/2011
1	Biphasic InsulinsIBA 05/2010
1	Short-Acting InsulinIBA 05/2008
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 05/2008
1	Insulin Glargine (Lantus)FDA Link 05/2008
1	Protamines (Protamine Sulfate)FDA Link 12/2005
1	Insulin AntibodiesIBA 12/2005
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2004
1	Insulin-Like PeptidesIBA 01/2004
1	Insulin-Like Growth Factor Binding ProteinsIBA 01/2004
1	Insulin-Like Growth Factor Binding Protein 3IBA 01/2004
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2004
1	repaglinide (Prandin)FDA Link 09/2000
1	SolutionsIBA 09/2000

Therapy/Procedure

3	Therapeutics 02/2011 - 09/2000
2	Injections 11/2006 - 12/2005
1	Subcutaneous Injections 05/2008
1	Subcutaneous Infusions 05/2008
1	Patient Transfer (Patient Dumping) 01/2005
1	Hearing Aids (Hearing Aid) 05/2001